A novel nanobody specific for respiratory surfactant protein A has potential for lung targeting

References

• RaissyHHKellyHWHarkinsMSzeflerSJInhaled corticosteroids in lung diseasesAm J Respir Crit Care Med2013187879880323370915
   PubMed Web of Science ®Google Scholar
• ZervasESamitasKGagaMBegheBFabbriLMInhaled corticosteroids in COPD: pros and consCurr Drug Targets201314219222423256718
   PubMed Web of Science ®Google Scholar
• KarraNNassarTLaengerFBenitaSBorlakJSafety and proof-of-concept efficacy of inhaled drug loaded nano- and immunonanoparticles in a c-Raf transgenic lung cancer modelCurr Cancer Drug Targets2013131112923030233
   PubMed Web of Science ®Google Scholar
• DandekarPVenkataramanCMehraAPulmonary targeting of nanoparticle drug matricesJ Aerosol Med Pulm Drug Deliv201023634335320455773
   PubMed Web of Science ®Google Scholar
• ZhangXSunPBiRWangJZhangNHuangGTargeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammationJ Drug Target200917539940719263265
   PubMed Web of Science ®Google Scholar
• WeiYZhaoLPassive lung-targeted drug delivery systems via intravenous administrationPharm Dev Technol201419212913623336716
   PubMed Web of Science ®Google Scholar
• IrwinRSRichardsonNDSide effects with inhaled corticosteroids: the physician’s perceptionChest20061301 Suppl41S53S16840367
   PubMed Web of Science ®Google Scholar
• MayaSKumarLGSarmentoBCetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cellsCarbohydr Polym201393266166923499109
   PubMed Web of Science ®Google Scholar
• KouchakzadehHShojaosadatiSATahmasebiFShokriFOptimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticlesInt J Pharm20134471–2626923454849
   PubMed Web of Science ®Google Scholar
• BanerjeeRTyagiPLiSHuangLAnisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cellsInt J Cancer2004112469370015382053
   PubMed Web of Science ®Google Scholar
• OmidfarKAmjad ZanjaniFSHaghAGAziziMDRasouliSJKashanianSEfficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobodyMol Biol Rep201340126737674524052234
   PubMed Web of Science ®Google Scholar
• HeukersRAltintasIRaghoenathSTargeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticlesBiomaterials201435160161024139763
   PubMed Web of Science ®Google Scholar
• LiLWartchowCADanthiSNA novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticlesInt J Radiat Oncol Biol Phys20045841215122715001266
   PubMed Web of Science ®Google Scholar
• AkiyamaJHoffmanABrownCTissue distribution of surfactant proteins A and D in the mouseJ Histochem Cytochem200250799399612070278
   PubMed Web of Science ®Google Scholar
• KingmaPSWhitsettJAIn defense of the lung: surfactant protein A and surfactant protein DCurr Opin Pharmacol20066327728316580255
   PubMed Web of Science ®Google Scholar
• BarreiraERPreciosoARBoussoAPulmonary surfactant in respiratory syncytial virus bronchiolitis: the role in pathogenesis and clinical implicationsPediatr Pulmonol201146541542021194166
   PubMed Web of Science ®Google Scholar
• ChenXYWangSMLiNCreation of lung-targeted dexamethasone immunoliposome and its therapeutic effect on bleomycin-induced lung injury in ratsPloS One201383e5827523516459
   PubMed Web of Science ®Google Scholar
• ChapmanAPPEGylated antibodies and antibody fragments for improved therapy: a reviewAdv Drug Deliv Rev200254453154512052713
   PubMed Web of Science ®Google Scholar
• Hamers-CastermanCAtarhouchTMuyldermansSNaturally occurring antibodies devoid of light chainsNature199336364284464488502296
   PubMed Web of Science ®Google Scholar
• RahbarizadehFAhmadvandDSharifzadehZNanobody; an old concept and new vehicle for immunotargetingImmunol Invest201140329933821244216
   PubMed Web of Science ®Google Scholar
• MuyldermansSBaralTNRetamozzoVCCamelid immunoglobulins and nanobody technologyVet Immunol Immunopathol20091281–317818319026455
   PubMed Web of Science ®Google Scholar
• EbrahimizadehWMousavi GargariSRajabibazlMSafaee ArdekaniLZareHBakheradHIsolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypesAppl Microbiol Biotechnol201397104457446623135228
   PubMed Web of Science ®Google Scholar
• van der LindenRHFrenkenLGde GeusBComparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodiesBiochim Biophys Acta199914311374610209277
   PubMed Web of Science ®Google Scholar
• HuangLMuyldermansSSaerensDNanobodies: proficient tools in diagnosticsExpert Rev Mol Diagn201010677778520843201
   PubMed Web of Science ®Google Scholar
• Van BockstaeleFHolzJBRevetsHThe development of nanobodies for therapeutic applicationsCurr Opin Investig Drugs2009101112121224
   PubMed Web of Science ®Google Scholar
• De GroeveKDeschachtNDe KoninckCNanobodies as tools for in vivo imaging of specific immune cell typesJ Nucl Med201051578278920395332
   PubMed Web of Science ®Google Scholar
• Alvarez-RuedaNLadjemiMZBeharGA llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: immunogenicity and efficacyVaccine200927354826483319523913
   PubMed Web of Science ®Google Scholar
• ArdekaniLSGargariSLRasooliIA novel nanobody against urease activity of Helicobacter pyloriInt J Infect Dis2013179e723e72823561799
   PubMed Web of Science ®Google Scholar
• RooversRCLaeremansTHuangLEfficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodiesCancer Immunol Immunother200756330331716738850
   PubMed Web of Science ®Google Scholar
• DoylePJArbabi-GhahroudiMGaudetteNCloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenolMol Immunol200845143703371318632156
   PubMed Web of Science ®Google Scholar
• GiordanoRJEdwardsJKTuderRMArapWPasqualiniRCombinatorial ligand-directed lung targetingProc Am Thorac Soc20096541141519687212
   PubMedGoogle Scholar
• WuMPasulaRSmithPAMartinWJ2ndMapping alveolar binding sites in vivo using phage peptide librariesGene Ther200310171429143612900757
   PubMed Web of Science ®Google Scholar
• RajotteDRuoslahtiEMembrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage displayJ Biol Chem199927417115931159810206967
   PubMed Web of Science ®Google Scholar
• HeukersRvan BergenEnHenegouwenPMOliveiraSNanobody-photosensitizer conjugates for targeted photodynamic therapyNanomedicine20141071441145124394212
   PubMed Web of Science ®Google Scholar
• BakheradHMousavi GargariSLRasooliIIn vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH)Mol Biotechnol201355215916723666874
   PubMed Web of Science ®Google Scholar
• Siller-MatulaJMKrumphuberJJilmaBPharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseasesBr J Pharmacol2010159350251720050853
   PubMed Web of Science ®Google Scholar
• RyckaertSPardonESteyaertJCallewaertNIsolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastorisJ Biotechnol20101452939819861136
   PubMed Web of Science ®Google Scholar
• TehYHKavanaghTAHigh-level expression of camelid nanobodies in Nicotiana benthamianaTransgenic Res201019457558619862637
   PubMed Web of Science ®Google Scholar
• HanZZhangBWangYEZuoYYSuWWSelf-assembled amyloid-like oligomeric-cohesin scaffoldin for augmented protein display on the Saccharomyces cerevisiae cell surfaceAppl Environ Microbiol20127893249325522344635
   PubMed Web of Science ®Google Scholar
• LentzEMGaraicoecheaLAlfanoEFParrenoVWigdorovitzABravo-AlmonacidFFTranslational fusion and redirection to thylakoid lumen as strategies to improve the accumulation of a camelid antibody fragment in transplastomic tobaccoPlanta2012236270371422526499
   PubMed Web of Science ®Google Scholar
• MonegalAOlichonABeryNFilleronTFavreGde MarcoASingle domain antibodies with VH hallmarks are positively selected during panning of llama (Lama glama) naïve librariesDev Comp Immunol201236115015621767565
   PubMed Web of Science ®Google Scholar
• HarmsenMMDe HaardHJProperties, production, and applications of camelid single-domain antibody fragmentsAppl Microbiol Biotechnol2007771132217704915
   PubMed Web of Science ®Google Scholar
• VuKBGhahroudiMAWynsLMuyldermansSComparison of llama VH sequences from conventional and heavy chain antibodiesMol Immunol19973416–17112111319566760
   PubMed Web of Science ®Google Scholar